KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib (Q36805595)
Jump to navigation
Jump to search
scientific article published on 17 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib |
scientific article published on 17 November 2015 |
Statements
1 reference
KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib (English)
1 reference
Ignacio I Wistuba
1 reference
Roy Herbst
1 reference
John V Heymach
1 reference
Monique B Nilsson
1 reference
Uma Giri
1 reference
Jayanthi Gudikote
1 reference
Ximing Tang
1 reference
Wei Lu
1 reference
Hai Tran
1 reference
Youhong Fan
1 reference
Andrew Koo
1 reference
Lixia Diao
1 reference
Pan Tong
1 reference
Jing Wang
1 reference
Bruce E Johnson
1 reference
Andy Ryan
1 reference
Alan Webster
1 reference
Philip Rowe
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference